Head-to-head · WeighScore
Medi-Weightloss vs RxSpan MD
By GLP-1 ScorecardUpdated
Score comparison
RxSpan MD has the higher recorded score — 84.3/100 to 69.6/100.
RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.
Before you choose
Neither seller publishes a medication price, so the Medi-Weightloss review and the RxSpan MD review are where to see what each one does disclose about fees, renewal and cancellation. Ask both for a written total, including any membership, before deciding.
If neither one fits, Medi-Weightloss vs Synergy Rx and MediRX vs RxSpan MD compare each of them with another graded program, and the list of alternatives to Medi-Weightloss ranks the programs closest to Medi-Weightloss on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Medi-Weightloss | RxSpan MD |
|---|---|---|
| WeighScore | 69.6/100 | 84.3/100 |
| Grade | C | B |
| Site position | #134 | #4 |
| Semaglutide | Medication-inclusive price not established; confirm clinic quote | Current compounded quote unconfirmed |
| Tirzepatide | Medication-inclusive price not established; local first-month offers vary | Current compounded quote unconfirmed |
| Coverage | Clinic-specific; telehealth at participating locations | Confirm treatment availability during intake |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #134 · C
Strengths
- Describes recurring clinic visits, nutrition guidance and body-composition reviews.
- Lists branded Wegovy, Zepbound and Saxenda alongside compounded injection options, subject to provider assessment.
- Publishes a pharmacy network; the provider chooses the dispensing assignment.
- Insurance and HSA/FSA options are described, with coverage dependent on location and plan.
What to consider
- The local $199 initial visit and $199 starting program are not a national branded-medication price.
- Medication, labs, supplements and other services can cost extra; get the complete local quote.
- Early visits can be weekly, and telehealth is not assured at every clinic.
- The selected membership, prepayment, renewal and refund agreement still needs confirmation.
Site position #4 · B
Strengths
- Current public catalog lists Ozempic, Wegovy, Mounjaro and Zepbound
- Public terms describe independent healthcare providers
- Homepage describes messaging and care-team appointments
What to consider
- Homepage advertises compounded plans that the current catalog did not substantiate
- Current oral GLP-1 availability is unconfirmed
- Prior compounded prices are not a current quote; selected dose, supply, pharmacy and fee inclusions need confirmation
- Public terms do not establish unused prepaid-treatment refund amounts
Featured provider
RxSpan MD
RxSpan MD scores 84.3/100 (B). RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.